Search research articles
Contact Us
Filters
Showing results (1321-1330 of 1,451) with videos related to
Page
of 146
Sort By:
Hepatology (Baltimore, Md.)
|
September 3, 2014
Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis
Chao Wang, Yuanlin Zhao, Xing Gao, et al.
Frontiers in Pharmacology
|
September 6, 2021
The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based Study
Zhong-Bin Li, Dan-Dan Chen, Qing-Juan He, et al.
Frontiers in Pharmacology
|
February 20, 2024
Scaling up production of recombinant human basic fibroblast growth factor in an <i>Escherichia coli</i> BL21(DE3) plysS strain and evaluation of its pro-wound healing efficacy
Le Li, Bingjie Yu, Yingji Lai, et al.
Frontiers in Immunology
|
September 12, 2025
Correction: The efficacy and safety of tislelizumab with or without tyrosine kinase inhibitor as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative resection
Ning Peng, Lin-Feng Mao, Jia-Yong Su, et al.
Neuroendocrinology
|
January 11, 2023
Alterations of Spontaneous Cortical and Subcortical Activity in Type 2 Diabetes Mellitus with and without Depression
Jing Tian, Rui-Fang Liu, Zhou-Le Li, et al.
Microorganisms
|
April 26, 2025
Natural Infection of Omicron BA.5.2 in Patients Provides Broad Immune Responses Against SARS-CoV-2
Le Li, Tang Feng, Quan Shen, et al.
Nature Communications
|
November 10, 2018
TAp73-induced phosphofructokinase-1 transcription promotes the Warburg effect and enhances cell proliferation
Le Li, Lijia Li, Wei Li, et al.
Journal of Translational Medicine
|
October 11, 2012
Comparing serum levels of cardiac biomarkers in cancer patients receiving chemotherapy and subjects with chronic periodontitis
WingsT Y Loo, Yuan Yue, Chang-bin Fan, et al.
Frontiers in Immunology
|
July 3, 2025
The efficacy and safety of tislelizumab with or without tyrosine kinase inhibitor as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative resection
Ning Peng, Lin-Feng Mao, Jia-Yong Su, et al.
International Immunopharmacology
|
December 21, 2023
Sanguinarine modulates microglial function via PPARγ activation and protects against CNS demyelination
Dan-Jie Wang, Xiao Wang, Shu-le Li, et al.
Page
of 146
Search research articles
Search
Showing results (1321-1330 of 1,451) with videos related to
Sort By:
Page
of 146
Hepatology (Baltimore, Md.)
|
September 3, 2014
Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis
Chao Wang, Yuanlin Zhao, Xing Gao, et al.
Frontiers in Pharmacology
|
September 6, 2021
The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based Study
Zhong-Bin Li, Dan-Dan Chen, Qing-Juan He, et al.
Frontiers in Pharmacology
|
February 20, 2024
Scaling up production of recombinant human basic fibroblast growth factor in an <i>Escherichia coli</i> BL21(DE3) plysS strain and evaluation of its pro-wound healing efficacy
Le Li, Bingjie Yu, Yingji Lai, et al.
Frontiers in Immunology
|
September 12, 2025
Correction: The efficacy and safety of tislelizumab with or without tyrosine kinase inhibitor as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative resection
Ning Peng, Lin-Feng Mao, Jia-Yong Su, et al.
Neuroendocrinology
|
January 11, 2023
Alterations of Spontaneous Cortical and Subcortical Activity in Type 2 Diabetes Mellitus with and without Depression
Jing Tian, Rui-Fang Liu, Zhou-Le Li, et al.
Microorganisms
|
April 26, 2025
Natural Infection of Omicron BA.5.2 in Patients Provides Broad Immune Responses Against SARS-CoV-2
Le Li, Tang Feng, Quan Shen, et al.
Nature Communications
|
November 10, 2018
TAp73-induced phosphofructokinase-1 transcription promotes the Warburg effect and enhances cell proliferation
Le Li, Lijia Li, Wei Li, et al.
Journal of Translational Medicine
|
October 11, 2012
Comparing serum levels of cardiac biomarkers in cancer patients receiving chemotherapy and subjects with chronic periodontitis
WingsT Y Loo, Yuan Yue, Chang-bin Fan, et al.
Frontiers in Immunology
|
July 3, 2025
The efficacy and safety of tislelizumab with or without tyrosine kinase inhibitor as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative resection
Ning Peng, Lin-Feng Mao, Jia-Yong Su, et al.
International Immunopharmacology
|
December 21, 2023
Sanguinarine modulates microglial function via PPARγ activation and protects against CNS demyelination
Dan-Jie Wang, Xiao Wang, Shu-le Li, et al.
Page
of 146